与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:FLUCYTOSINE 剂型/给药途径:CAPSULE;ORAL 规格:250MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
017001 |
001 |
NDA |
ANCOBON |
FLUCYTOSINE |
CAPSULE;ORAL |
250MG |
Prescription |
Yes |
No |
AB |
Approved Prior to Jan 1, 1982
|
BAUSCH |
201566 |
001 |
ANDA |
FLUCYTOSINE |
FLUCYTOSINE |
CAPSULE;ORAL |
250MG |
Prescription |
No |
No |
AB |
2011/06/28
|
SIGMAPHARM LABS LLC |
204652 |
001 |
ANDA |
FLUCYTOSINE |
FLUCYTOSINE |
CAPSULE;ORAL |
250MG |
Prescription |
No |
No |
AB |
2017/07/07
|
NOVEL LABS INC |
206550 |
001 |
ANDA |
FLUCYTOSINE |
FLUCYTOSINE |
CAPSULE;ORAL |
250MG |
Prescription |
No |
No |
AB |
2017/10/17
|
HIKMA |
213665 |
001 |
ANDA |
FLUCYTOSINE |
FLUCYTOSINE |
CAPSULE;ORAL |
250MG |
Prescription |
No |
No |
AB |
2020/05/01
|
AUROBINDO PHARMA LTD |
活性成分:FLUCYTOSINE 剂型/给药途径:CAPSULE;ORAL 规格:500MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
017001 |
002 |
NDA |
ANCOBON |
FLUCYTOSINE |
CAPSULE;ORAL |
500MG |
Prescription |
Yes |
Yes |
AB |
Approved Prior to Jan 1, 1982
|
BAUSCH |
201566 |
002 |
ANDA |
FLUCYTOSINE |
FLUCYTOSINE |
CAPSULE;ORAL |
500MG |
Prescription |
No |
No |
AB |
2011/06/28
|
SIGMAPHARM LABS LLC |
204652 |
002 |
ANDA |
FLUCYTOSINE |
FLUCYTOSINE |
CAPSULE;ORAL |
500MG |
Prescription |
No |
No |
AB |
2017/07/07
|
NOVEL LABS INC |
206550 |
002 |
ANDA |
FLUCYTOSINE |
FLUCYTOSINE |
CAPSULE;ORAL |
500MG |
Prescription |
No |
No |
AB |
2017/10/17
|
HIKMA |
213665 |
002 |
ANDA |
FLUCYTOSINE |
FLUCYTOSINE |
CAPSULE;ORAL |
500MG |
Prescription |
No |
No |
AB |
2020/05/01
|
AUROBINDO PHARMA LTD |